Search results
Results from the WOW.Com Content Network
Its current director is Dr. Richard Woychik, who is also concurrently the director of the National Toxicology Program. [12] The deputy director is Dr. Trevor Archer. The director of the NIEHS reports to the director of the NIH, of which the NIEHS is a member agency. [13] NIEHS is composed of:
ntp.niehs.nih.gov The National Toxicology Program ( NTP ) is an inter-agency program run by the United States Department of Health and Human Services to coordinate, evaluate, and report on toxicology within public agencies.
The NIH Office of Science Policy works on a wide range of issues including biosafety, [2] biosecurity, [3] genetic testing, genomic data sharing, [4] human subjects protections, [5] the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports ...
The Drug Abuse Warning Network (DAWN) and National Household Survey on Drug Abuse (NHSDA) were created in 1972. In 1974 NIDA was established as part of the Alcohol, Drug Abuse, and Mental Health Administration and given authority over the DAWN and NHSDA programs.
The mission of the NIH OTT is to improve public health through the management of inventions made by NIH and FDA scientists and the development of intellectual property policies for NIH's intramural and extramural research programs. In doing so, OTT serves a leading role in public sector biomedical technology transfer policy and practice.
Nearly half of all 3,100 counties in America have no doctors certified to prescribe buprenorphine by the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Administration, according to a Huffington Post analysis. Hundreds of counties have very few certified doctors.
The Substance Abuse and Mental Health Services Administration (SAMHSA; pronounced / ˈ s æ m s ə /) is a branch of the U.S. Department of Health and Human Services.SAMHSA is charged with improving the quality and availability of treatment and rehabilitative services in order to reduce illness, death, disability, and the cost to society resulting from substance abuse and mental illnesses.
The Drug, Healthcare and Patient Safety is a peer-reviewed healthcare journal covering patient safety issues. It was established in 2009 and is published by Dove Medical Press . The journal is abstracted and indexed in EMBASE and Scopus .